Mortality Benefit of Alirocumab: A Bayesian Perspective
Background The ODYSSEY OUTCOMES (Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome) trial demonstrated that alirocumab reduced major cardiovascular events. However, because of the hierarchical testing strategy used for the multiple outcomes examined, the observed reduction in all‐...
Zapisane w:
| Główni autorzy: | , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Wiley
2019-10-01
|
| Seria: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.ahajournals.org/doi/10.1161/JAHA.119.013170 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|